Aspira Pathlab & Diagnostics share news, announcements and annual reports
BSE: 540788Healthcare ServicesSmall Cap
Aspira Pathlab & Diagnostics Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2017
Last close ₹133.80up ₹6.35 (4.98%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹127.45.
30 Oct: open ₹127.45, high ₹133.80, low ₹122.15
52-week range of traded prices to 30 Oct 2026
₹49.00Low, 15 Apr 2026₹149.99High, 30 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹138 Cr3,082nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 11.26
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −3.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −4.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.11
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,135
Aspira Pathlab & Diagnostics board meetings
101 filed, newest first. Page 2 of 3.
May 2022
Feb 2022
12 Feb · Board meeting
7 Feb · Board meeting
Meeting on 12 Feb 2022: quarterly results
Nov 2021
13 Nov · Board meeting
13 Nov · Board meeting
8 Nov · Board meeting
Meeting on 13 Nov 2021: quarterly results
Aug 2021
14 Aug · Board meeting
9 Aug · Board meeting
Meeting on 14 Aug 2021: quarterly results and annual general meeting
Jun 2021
5 Jun · Board meeting
May 2021
28 May · Board meeting
Meeting on 5 Jun 2021: audited results
Feb 2021
8 Feb · Board meeting
Meeting on 13 Feb 2021: quarterly results
Nov 2020
3 Nov · Board meeting
Meeting on 10 Nov 2020: quarterly results
Aug 2020
25 Aug · Board meeting
Meeting on 29 Aug 2020: annual general meeting
Jul 2020
23 Jul · Board meeting
Meeting on 28 Jul 2020: quarterly results and preferential issue of shares
Jun 2020
8 Jun · Board meeting
Meeting on 13 Jun 2020: audited results
Jan 2020
27 Jan · Board meeting
Meeting on 4 Feb 2020: quarterly results
Nov 2019
2 Nov · Board meeting
Oct 2019
29 Oct · Board meeting
Meeting on 2 Nov 2019: quarterly results
Aug 2019
19 Aug · Board meeting
Meeting on 21 Aug 2019: preferential issue of shares14 Aug · Board meeting
Jul 2019
15 Jul · Board meeting
Meeting on 20 Jul 2019: quarterly results
May 2019
13 May · Board meeting
Meeting on 18 May 2019: audited results
Jan 2019
Oct 2018
Aug 2018
May 2018
Apr 2018
Feb 2018